A Study Evaluating the Safety of Tocilizumab in Addition to Standard of Care Premedication Given Before Obinutuzumab + Chlorambucil in Participants With Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Comorbidities
Clinical trial NCT02336048 · TERMINATED
Trial details
- NCT number
- NCT02336048
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-26
- Primary completion
- 2018-09-21
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.